Both in Surgical Instruments
NexGel vs Vivos Therapeutics
Over the past year NXGL returned −90.9% and VVOS returned −95.3%; their daily moves had a correlation of 0.06.
NXGL −90.9% VVOS −95.3%Growth of $1, one year, split-adjusted
| Metric | NXGL | VVOS |
|---|---|---|
| Price | $4.01 | $0.1112 |
| Market cap | $2.0M | $2.2M |
| Today | −10.49% | +1.27% |
| 1 month | +16.0% | −27.7% |
| 6 months | −66.6% | −84.6% |
| Year to date | −87.5% | −94.5% |
| 1 year | −91.5% | −95.5% |
| Revenue growth (YoY) | +27.8% | +34.9% |
| Gross margin | 30.1% | 57.3% |
| Net margin | −98.6% | −106.4% |
| P/E (TTM) | — | — |
| Price / sales | 0.2× | 0.1× |
| Net cash | -$2.9M | -$6.5M |
| Dividend yield | — | — |
| Volatility (60d) | 934.9% | 89.9% |
| Short % of float | 1.3% | 7.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).